ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
ChemRar’s Avifavir demonstrates effectiveness against SARS-CoV-2 variants
December 29, 2021Russia-based ChemRar Group has reported that its drug, Avifavir (favipiravir), demonstrated effectiveness against several SARS-CoV-2 variants, including Delta and Omicron. -
RDIF and ChemRar agree to supply Avifavir to 17 countries
September 27, 2020The Russian Direct Investment Fund (RDIF) and ChemRar Group will be supplying a Covid-19 drug, Avifavir, to 17 countries. -
Russia’s RDIF, ChemRar to boost production of Avifavir for Covid-19
July 06, 2020A joint venture established by the Russian Direct Investment Fund (RDIF) and ChemRar Group is set to boost production of Avifavir, which secured temporary approval from the Russian government to treat Covid-19.
Pharma Sources Insight January 2025
